Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Article

  • Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
    Shivendra V. Singh, Yan Zeng, Dong Xiao, Victor G. Vogel, Joel B. Nelson, Rajiv Dhir, Yamini B. Tripathi
    Molecular Cancer Therapeutics Nov 2005, 4 (11) 1747-1754; DOI: 10.1158/1535-7163.MCT-05-0223
  • Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
    Kimiko Ishiguro, Krishnamurthy Shyam, Philip G. Penketh, Alan C. Sartorelli
    Molecular Cancer Therapeutics Nov 2005, 4 (11) 1755-1763; DOI: 10.1158/1535-7163.MCT-05-0169
  • Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells
    Hiroji Uemura, Hitoshi Ishiguro, Yoji Nagashima, Takeshi Sasaki, Noboru Nakaigawa, Hisashi Hasumi, Shingo Kato, Yoshinobu Kubota
    Molecular Cancer Therapeutics Nov 2005, 4 (11) 1699-1709; DOI: 10.1158/1535-7163.MCT-04-0295
  • Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
    Roohangiz Safaei, Barrett J. Larson, Timothy C. Cheng, Michael A. Gibson, Shinji Otani, Wiltrud Naerdemann, Stephen B. Howell
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1595-1604; DOI: 10.1158/1535-7163.MCT-05-0102
  • Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells
    David Peters, John Freund, Robert L. Ochs
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1605-1616; DOI: 10.1158/1535-7163.MCT-04-0311
  • WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
    Teresa Kosakowska-Cholody, W. Marek Cholody, Anne Monks, Barbara A. Woynarowska, Christopher J. Michejda
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1617-1627; DOI: 10.1158/1535-7163.MCT-05-0170
  • YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells
    Yao-Ting Huang, Shiow-Lin Pan, Jih-Hwa Guh, Ya-Ling Chang, Fang-Yu Lee, Sheng-Chu Kuo, Che-Ming Teng
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1628-1635; DOI: 10.1158/1535-7163.MCT-05-0090
  • Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells
    David L. Morse, Heather Gray, Claire M. Payne, Robert J. Gillies
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1495-1504; DOI: 10.1158/1535-7163.MCT-05-0130
  • Counteracting tumor radioresistance by targeting DNA repair
    Dörthe Schaue, William H. McBride
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1548-1550; DOI: 10.1158/1535-7163.MCT-05-CO1
  • Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer
    Curtis Balch, Pearlly Yan, Teresa Craft, Suzanne Young, David G. Skalnik, Tim H-M. Huang, Kenneth P. Nephew
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1505-1514; DOI: 10.1158/1535-7163.MCT-05-0216

Pages

  • Previous
  • Next
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 69
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement